A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

DUBLIN--(BUSINESS WIRE)--The "Diabetes Injection Pens Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030" ...

This new prefilled insulin injection pen has a unique spring-loaded mechanism. The pen has a no push-button extension at any dose and a low injection force, designed to make self-injecting easier for ...

Please provide your email address to receive an email when new articles are posted on . Miller-Owen: Close to 8 million U.S. residents with diabetes are on insulin therapy, and the clear majority use ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect adherence to injecting bolus insulin in people living with diabetes (PLWD), ...

Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...

Insulin therapy helps control blood sugar levels in diabetes. What type of insulin you take, how often you take it, and how it’s administered are all part of your individualized treatment plan. For ...

(HealthCentersOnline) - Using an insulin pen instead of syringe injections may improve compliance and reduce diabetic emergencies, new research suggests. All people with type 1 diabetes and some ...

(RTTNews) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling certain Insulin Glargine (Insulin glargine-yfgn) Injection prefilled pens due to the potential for ...

A small molecule made by gut microbes is rapidly emerging as one of the most intriguing new levers for controlling blood ...

One batch of Semglee prefilled insulin injection pens has been recalled by Mylan Pharmaceuticals for missing labels. Batch No. BF20003118, expiration August 2022 of Semglee (insulin glargine injection ...